$EHSI Cashflow Statement | Understand Stock

$EHSI

$0.90 +$0.00 (0.0%) Close

$EHSI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization of property and equipment
Amortization of operating lease right-of-use asset
Loss from investments in unconsolidated entities
Loss (income) from investments in unconsolidated entities, net
Stock issued as compensation
Distributed earnings from unconsolidated entities
Accrued interest from notes receivable
Impairment of Goodwill
Deferred income taxes
Stock-based compensation expense
Impairment of goodwill and intagible assets

Changes in:
Accounts receivable
Income taxes payable
Other current assets
Customer advances
Accounts payable and accrued expenses
Stock receivable
Operating lease right-of-use liability
Net cash provied by (used in) operating activities
Cash flows from investing activities:
Advances to unconsolidated entities
Distributed earnings from unconsolidated entities
Repayments of loans to unconsolidated entities
(Loss) gain from investment in unconsolidated entities
Principal payments received under sales-type sublease
Capital contributions to unconsolidated entities
Loss from investment in unconsolidated entities
Sale of shares (deposited in 2023 for 2024 transaction)
Distribution from unconsolidated entities outstanding
Capitalization of software development
Website development costs
Fixed assets
Net cash used in investing activities

Cash flows from financing activities:
Issuance of shares from prior period
Common stock issued
Additional capital from issuance of common stock
Additional capital from sale of common stock
Net cash provided by financing activities
Net change in cash and cash equivalents
Cash and cash equivalents - beginning of period
Cash and cash equivalents - end of period
Interest
Income taxes
Conversion of prior advances to unconsolidated entity in lieu of cash payment for capital contribution
Issuance of subsidiary shares in exchange for a controlling interest in Elite Health Plan, Inc.
Supplemental disclosure of noncash investing and financing activities
Stock subscriptions receivable
Common stock subscribed
Stock to be issued
Non-cash stock compensation

Comments